definitive healthcare is the leading provider of data and intelligence on hospitals, physicians and other healthcare providers. their product suite provides the most comprehensive and highest quality data available anywhere on over 8,100 hospitals and idns, 7,300 ambulatory surgery centers, 11,000 imaging centers, 38,000 long-term care facilities, 1,200 acos and hies, 197,000 physician groups, 1.3 million physicians, and 750 canadian hospitals. the company’s data provides clients with the analytics and insight needed to effectively segment and research the healthcare provider market. definitive healthcare is backed by spectrum equity. for more information or to trial the service, visit www.definitivehc.com.
Company profile
Ticker
DH
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Microsoft • Oracle • Mobileye Global Inc - Ordinary Shares • Activision Blizzard • Gen Digital • Vmware • Adobe • Salesforce • BlackBerry • Dayforce ...
SEC CIK
Corporate docs
Subsidiaries
AIDH TopCo, LLC • AIDH Buyer, LLC • Definitive Healthcare Holdings, LLC • Definitive Healthcare, LLC • Analytical Wizards, Inc • Analytical Wizards Services Private Ltd • Monocl Holding Company, LLC • Monocl Company, LLC • Monocl AB • Healthcare Sales Enablement, LLC ...
DH stock data
Latest filings (excl ownership)
ARS
2023 FY
Annual report to shareholders
9 Apr 24
DEFA14A
Additional proxy soliciting materials
9 Apr 24
DEF 14A
Definitive proxy
9 Apr 24
S-8
Registration of securities for employees
28 Feb 24
10-K
2023 FY
Annual report
28 Feb 24
8-K
Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2023
28 Feb 24
8-K
Definitive Healthcare Announces CEO Transition
16 Jan 24
8-K
Cost Associated with Exit or Disposal Activities
4 Jan 24
8-K
Departure of Directors or Certain Officers
21 Nov 23
10-Q
2023 Q3
Quarterly report
2 Nov 23
Transcripts
DH
Earnings call transcript
2023 Q4
28 Feb 24
DH
Earnings call transcript
2023 Q3
2 Nov 23
DH
Earnings call transcript
2023 Q2
14 Aug 23
DH
Earnings call transcript
2023 Q1
4 May 23
DH
Earnings call transcript
2023 Q1
4 May 23
DH
Earnings call transcript
2022 Q4
23 Feb 23
DH
Earnings call transcript
2022 Q3
3 Nov 22
DH
Earnings call transcript
2022 Q2
7 Aug 22
DH
Earnings call transcript
2022 Q1
7 May 22
DH
Earnings call transcript
2021 Q4
24 Feb 22
Latest ownership filings
4
Richard Douglas Booth
18 Mar 24
4
Kate Marie Shamsuddin
18 Mar 24
4
Jason Ronald Krantz
18 Mar 24
4
Jason Ronald Krantz
20 Feb 24
4
Kate Marie Shamsuddin
16 Feb 24
4
Jonathan Maack
16 Feb 24
4
Carrie Lazorchak
16 Feb 24
4
Richard Douglas Booth
16 Feb 24
SC 13G/A
ADVENT INTERNATIONAL, L.P.
14 Feb 24
SC 13G/A
Krantz Jason Ronald
13 Feb 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 77.46 mm | 77.46 mm | 77.46 mm | 77.46 mm | 77.46 mm | 77.46 mm |
Cash burn (monthly) | 18.31 mm | 12.61 mm | 98.46 mm | 28.03 mm | (no burn) | (no burn) |
Cash used (since last report) | 125.72 mm | 86.62 mm | 676.11 mm | 192.45 mm | n/a | n/a |
Cash remaining | -48.26 mm | -9.16 mm | -598.65 mm | -114.99 mm | n/a | n/a |
Runway (months of cash) | -2.6 | -0.7 | -6.1 | -4.1 | n/a | n/a |
Institutional ownership, Q3 2023
13F holders | Current |
---|---|
Total holders | 135 |
Opened positions | 18 |
Closed positions | 18 |
Increased positions | 57 |
Reduced positions | 36 |
13F shares | Current |
---|---|
Total value | 937.01 bn |
Total shares | 142.18 mm |
Total puts | 17.10 k |
Total calls | 28.80 k |
Total put/call ratio | 0.6 |
Largest owners | Shares | Value |
---|---|---|
Advent International | 62.49 mm | $499.32 bn |
SEA VII Management | 24.48 mm | $0.00 |
JPM JPMorgan Chase & Co. | 5.07 mm | $40.52 bn |
Conestoga Capital Advisors | 4.93 mm | $39.36 bn |
Vanguard | 4.33 mm | $34.61 bn |
Brown Advisory | 3.97 mm | $31.70 bn |
BLK Blackrock | 3.76 mm | $30.01 bn |
Bamco | 3.50 mm | $28.00 bn |
Riverbridge Partners | 2.61 mm | $20.84 bn |
Fred Alger Management | 2.56 mm | $20.45 bn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
14 Mar 24 | Booth Richard Douglas | Class A Common Stock | Payment of exercise | Dispose F | No | No | 8.09 | 993 | 8.03 k | 513,417.173 |
14 Mar 24 | Kate Marie Shamsuddin | Class A Common Stock | Payment of exercise | Dispose F | No | No | 8.09 | 1,044 | 8.45 k | 324,786 |
14 Mar 24 | Jason Ronald Krantz | Class A Common Stock | Payment of exercise | Dispose F | No | No | 8.09 | 2,808 | 22.72 k | 902,650 |
14 Feb 24 | Kate Marie Shamsuddin | Class A Common Stock | Grant | Acquire A | No | No | 0 | 121,831 | 0.00 | 325,830 |
14 Feb 24 | Jonathan Maack | Class A Common Stock | Grant | Acquire A | No | No | 0 | 214,995 | 0.00 | 709,671 |
News
What 4 Analyst Ratings Have To Say About Definitive Healthcare
1 Mar 24
Barclays Maintains Equal-Weight on Definitive Healthcare, Raises Price Target to $11
1 Mar 24
Challenging Times For Definitive Healthcare: Analysts Highlight Sluggish Growth And Recovery Efforts In Q4 Analysis
29 Feb 24
Canaccord Genuity Maintains Hold on Definitive Healthcare, Raises Price Target to $10
29 Feb 24
Definitive Healthcare Sees FY24 Revenue $263M-$269M Vs $270.29M Estimate
28 Feb 24
Press releases
Definitive Healthcare Announces Timing of Its First Quarter 2024 Financial Results Conference Call and Webcast
23 Apr 24
VML and Definitive Healthcare announce partnership to transform key opinion leader management
22 Mar 24
Definitive Healthcare earns 2024 Middle Market Leader Award from Boston Business Journal
14 Mar 24
Definitive Healthcare Announces Timing of Its Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast
14 Feb 24